Get started
Author

Qingfeng Xue

Colon cancer recurrence-associated genes revealed by WGCNA co-expression network analysis
2017 · Xiaofeng Zhai, Qingfeng Xue, et al. · Molecular Medicine Reports · 127
PDF
Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature
2022 · Jing He, Ziwei Chen, et al. · Journal of Translational Medicine · 66
PDF
Holistic View of ALK TKI Resistance in ALK-Positive Anaplastic Large Cell Lymphoma
2022 · Yuan Wang, Jing He, et al. · Frontiers in Oncology · 13
PDF
Single-cell RNA sequencing in double-hit lymphoma: IMPDH2 induces the progression of lymphoma by activating the PI3K/AKT/mTOR signaling pathway
2023 · Guangcan Gao, Qingfeng Xue, et al. · International Immunopharmacology · 11
Primary Osteosarcoma of the Breast: A Rare Case Report and Literature Review
2022 · Shike Li, Qingfeng Xue, et al. · Frontiers in Oncology · 9
Block of Proliferation 1 Promotes Proliferation, Invasion and Epithelial Mesenchymal Transformation in Gastric Cancer
2022 · Jing He, Ziwei Chen, et al. · Oxidative Medicine and Cellular Longevity · 9
PDF
Classifier of cross talk genes predicts the prognosis of hepatocellular carcinoma
2017 · Xiaofeng Zhai, Qingfeng Xue, et al. · Molecular Medicine Reports · 8
PDF
Successful PD-1 inhibitor treatment in a patient with refractory transformed follicular lymphoma who failed to respond to CAR-T cell therapy: a case report and literature review
2021 · Weicheng Zheng, Qingfeng Xue, et al. · Cancer Biology & Therapy · 4
PDF
Association between environmental phenols and all-cause and cancer mortality
2022 · Jing He, Qingfeng Xue, et al. · Environmental Science and Pollution Research · 3
Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature
2022 · Jing He, Ziwei Chen, et al. · Research Square · 3
PDF
Pltp Regulates BCR Signaling and Tumor Microenvironment in Diffuse Large B-Cell Lymphoma through Reprogramming of Lipid Metabolism Environment
2022 · Wenyu Shi, Qingfeng Xue, et al. · Blood · 2
rWTC‐MBTA Vaccine, Alone and Enhanced with Anti‐PD1, Elicits Immune Responses against CNS and Peripheral B‐Cell Lymphoma
2025 · Yaping Zhang, Juan Ye, et al. · Advanced Science · 1
PDF
Synergistic Efficacy of Chidamide and LB100 in Sézary Syndrome via TNC Downregulation and PI3K / AKT / mTOR Dephosphorylation
2025 · Nan Chen, Yuan Wang, et al. · Cancer Science · 1
Case report: Immune modulation after PD-1 inhibitor therapy in a patient with extranodal NK/T-cell lymphoma secondary to chronic active Epstein-Barr virus disease unveiled by single-cell transcriptomics
2023 · Yao Wang, Minan Zhang, et al. · Frontiers in Immunology · 1
PDF
The WYZ-1 mouse glioblastoma stem cell model: A novel preclinical tool for tumor and therapy studies
2026 · Qingfeng Xue, Juan Ye, et al. · Cancer Letters
Optimizing rWTC-MBTA Vaccine Formulations, Dosing Regimens, and Cryopreservation Techniques to Enhance Anti-Metastatic Immunotherapy
2025 · Juan Ye, Herui Wang, et al. · International Journal of Molecular Sciences
PDF
Corrigendum to “Single-cell RNA sequencing in double-hit lymphoma: IMPDH2 induces the progression of lymphoma by activating the PI3K/AKT/mTOR signaling pathway” [Int. Immunopharmacol. 125(Part A) (2023) 111125]
2023 · Guangcan Gao, Qingfeng Xue, et al. · International Immunopharmacology
PP2A Inhibitor LB100 Enhances the Sensitivity of NPM-ALK+ALCL to Crizotinib and Reverses the Resistance of ALCL to Crizotinib
2022 · Wenyu Shi, Qingfeng Xue, et al. · Blood
HDACi Promotes the Occurrence of Ferroptosis in CTCL
2022 · Wenyu Shi, Yuan Wang, et al. · Blood
The value of combined detection of tumor markers in the diagnosis of primary liver cancer
2018 · Guifang Jiang, Baojiang Lyu, et al. · Zhongguo jiceng yiyao
Works count: 28
Citation count: 258
H-index: 7
I10-index: 4
Year
Topic
Type